No Data
No Data
Summit Therapeutics Price Target Maintained With a $40.00/Share by JMP Securities
Summit Therapeutics, Intel Among Monday's Market Cap Stock Movers
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday
Truist Financial Sticks to Their Buy Rating for Summit Therapeutics (SMMT)
S&P 500 Futures Drop In Premarket Trading; McCormick Vtg, TPG Lag
Summit Therapeutics Selloff Friday on Data Overdone, Says H.C. Wainwright